Tu1035 Characterization of Serious Adverse Events in Hepatitis C Genotype 1 Decompensated Cirrhotic Patients Who Underwent Sofosbuvir and Simeprevir Therapy (Cosmos Regimen)
Publication/Presentation Date
4-2015
Volume
148
Issue
4
Published In/Presented At
Peyton, A. (2015). Tu1035 Characterization of Serious Adverse Events in Hepatitis C Genotype 1 Decompensated Cirrhotic Patients Who Underwent Sofosbuvir and Simeprevir Therapy (Cosmos Regimen). LVHN Scholarly Works. Retrieved from https://scholarlyworks.lvhn.org/medicine/8971
Disciplines
Medicine and Health Sciences
Department(s)
Department of Medicine
Document Type
Article
COinS
